Background Data on the economic burden of head and neck cancers (HNCs) in Germany is
scarce. About 16%–28% of these cancers are associated with human papillomavirus (HPV) …

Background Genital warts are important causes of morbidity and their prevalence and
incidence can be used to evaluate the impact of HPV vaccination in a population. Methods …

Cytology-based screening programs for cervical cancer have been effective in reducing
cancer incidence and preventing premature deaths worldwide. However, there is concern …

OBJECTIVE: To describe the epidemiology of genital warts in England and Wales over the
period 1971 to 1994. METHOD: Retrospective study of available statistics. RESULTS: The …

Background: A vaccine has recently been licensed in many countries that protects against
the human papillomavirus types 6, 11, 16, and 18. Types 6 and 11 account for approximately …

Background Approximately 90% of genital warts are caused by human papillomavirus (HPV)
types 6 and 11. In the United States, HPV vaccination has been recommended for girls and …

In this Review, we describe the recent epidemiology of genital warts and postulate what the
future may hold as a result of the introduction of the quadrivalent human papillomavirus …

The current number of fungal infections occurring each year in Turkey is unknown. We
estimated the burden of serious human fungal diseases based on the population at risk …

Genital warts are one of the most commonly reported sexually transmitted diseases
worldwide. A variety of treatment options are available but few have been assessed in large …

Our aim was to determine country-specific attitudes and perceptions of patients with genital
warts and to understand the psychosexual impact of the disease and its treatment. We used …